Elevance Health Inc. ELV | NYSE

$365.96 -$0.52 | -0.14%

Next Earnings: Jan 22, 2025

Company Overview:

Market Cap: $84.87B
PE Ratio: 13.31
52-Week Range: $362.21 - $567.26
Dividend Yield (FWD): 1.78% ($6.52)

10 Year Performance Metrics:

Total Return (with DRIP): 226.56% (12.56% / yr)
Total Return (no DRIP): 215.74% (12.18% / yr)
Share Price: 184.86%
Dividend Increase: 272.57%
ELV 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

ELV Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
ELV Dividend CAGR:1Y: 10.14%2Y: 12.85%5Y: 15.30%10Y: 14.06%
Share Price
ELV Price CAGR:1Y: -20.31%2Y: -14.84%5Y: 3.85%10Y: 11.08%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ELV Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - ELV
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - ELV
14-Day FREE Trial Get Full Access Now!

ELV Earnings, Revenue, Cash & Debt, Shares Outstaning:

ELV - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ELV - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ELV - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ELV - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ELV - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ELV - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ELV - Revenue
14-Day FREE Trial Get Full Access Now!
ELV Revenue CAGR:1Y: 5.36%2Y: 6.32%5Y: 11.10%10Y: 9.30%
ELV - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ELV EPS CAGR:1Y: -20.00%2Y: -18.85%5Y: -0.85%10Y: 6.98%
ELV - Net Income
14-Day FREE Trial Get Full Access Now!
ELV Net Income CAGR:1Y: -21.18%2Y: -20.39%5Y: -3.00%10Y: 4.88%
ELV - EBITDA
14-Day FREE Trial Get Full Access Now!
ELV EBITDA CAGR:1Y: -3.75%2Y: -12.20%5Y: 2.26%10Y: 4.41%
ELV - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ELV Free Cash Flow CAGR:1Y: 2.22%2Y: -28.75%5Y: 10.93%10Y: 17.53%
ELV - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ELV Free Cash Flow / Share CAGR:1Y: 3.22%2Y: -27.75%5Y: 12.97%10Y: 19.30%
ELV - Gross Profit
14-Day FREE Trial Get Full Access Now!
ELV Gross Profit CAGR:1Y: -68.07%2Y: -42.20%5Y: -14.00%10Y: -4.11%
ELV - Expenses
14-Day FREE Trial Get Full Access Now!
ELV Expenses CAGR:1Y: 4.08%2Y: 4.33%5Y: 4.14%10Y: 9.07%
ELV - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ELV Shares Outstanding CAGR:1Y: -1.44%2Y: -1.90%5Y: -2.16%10Y: -1.48%
ELV - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ELV Share Buybacks CAGR:1Y: -87.50%2Y: -67.81%5Y: -37.79%10Y: -20.28%
ELV - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ELV Stock-Based Comp CAGR:1Y: -15.38%2Y: -2.20%5Y: -5.16%10Y: 6.02%
ELV - Dividends
14-Day FREE Trial Get Full Access Now!
ELV Dividend CAGR:1Y: 10.14%2Y: 12.85%5Y: 15.30%10Y: 14.06%
ELV - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ELV Revenue CAGR:1Y: 5.36%2Y: 6.32%5Y: 11.10%10Y: 9.30%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ELV - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ELV Actual Revenue CAGR:1Y: 5.36%2Y: 6.32%5Y: 11.10%10Y: 9.30%
ELV - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ELV Actual EPS CAGR:1Y: -20.00%2Y: -18.85%5Y: -0.85%10Y: 6.98%
ELV - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ELV Actual Net Income CAGR:1Y: -21.18%2Y: -20.39%5Y: -3.00%10Y: 4.88%
ELV - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ELV Actual EBITDA CAGR:1Y: -3.75%2Y: -12.20%5Y: 2.26%10Y: 4.41%

Ratios, Profit Margins & Return on Capital:

ELV - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ELV Net Profit Margin CAGR:1Y: -25.25%2Y: -25.09%5Y: -12.71%10Y: -4.04%
ELV - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ELV Gross Profit Margin CAGR:1Y: -69.69%2Y: -45.63%5Y: -22.59%10Y: -12.27%
ELV - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ELV - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ELV - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ELV - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

ELV Dividends Info:

Annual Dividend: $6.52
Forward Yield: 1.78%
Ex-Dividend Date: 2024-12-05
Lifetime Dividens / Share: $45.28

ELV Dividend History: Dates, Payments & Yield list

Below is a schedule of all ELV dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
12/05/202412/20/2024$1.6301.66%1.66%$392.98
09/10/202409/25/2024$1.6301.17%1.2%$544.15
06/10/202406/25/2024$1.6301.16%1.22%$536.25
03/07/202403/22/2024$1.6301.21%1.3%$501.58
12/05/202312/21/2023$1.4801.23%1.23%$482.05
09/07/202309/22/2023$1.4801.27%1.31%$450.33
06/08/202306/23/2023$1.4801.18%1.27%$466.26
03/09/202303/24/2023$1.4801.16%1.29%$459.96
12/02/202212/21/2022$1.2800.98%0.98%$523.60
09/08/202209/23/2022$1.2801.02%1.05%$489.35
06/09/202206/24/2022$1.2800.99%1.05%$486.20
03/09/202203/25/2022$1.2801%1.1%$465.37
12/02/202112/21/2021$1.1301.13%1.13%$399.74
09/09/202109/24/2021$1.1301.17%1.22%$371.43
06/09/202106/25/2021$1.1301.08%1.17%$385.96
03/09/202103/25/2021$1.1301.19%1.35%$333.78
12/04/202012/22/2020$0.9501.18%1.18%$323.27
09/09/202009/25/2020$0.9501.36%1.42%$267.42
06/09/202006/25/2020$0.9501.2%1.31%$291.01
03/13/202003/27/2020$0.9501.24%1.41%$270.34
12/04/201912/20/2019$0.8001.11%1.11%$287.38
09/09/201909/25/2019$0.8001.26%1.28%$250.45
06/07/201906/25/2019$0.8001.11%1.15%$278.13
03/15/201903/29/2019$0.8001.01%1.06%$303.00
12/04/201812/21/2018$0.7501.02%1.02%$292.92
09/07/201809/25/2018$0.7501.09%1.1%$271.90
06/07/201806/25/2018$0.7501.26%1.31%$229.59
03/08/201803/23/2018$0.7501.22%1.31%$228.79
12/04/201712/21/2017$0.7001.2%1.24%$224.95
09/07/201709/25/2017$0.7001.38%1.45%$192.64
06/07/201706/23/2017$0.6501.38%1.38%$188.33
03/08/201703/24/2017$0.6501.57%1.57%$165.65
12/01/201612/21/2016$0.6501.79%1.79%$145.17
09/07/201609/26/2016$0.6502.05%2.07%$125.85
06/08/201606/24/2016$0.6501.9%1.94%$134.20
03/08/201603/25/2016$0.6501.91%1.96%$132.48
12/02/201512/21/2015$0.6251.88%1.88%$132.92
09/08/201509/25/2015$0.6251.58%1.71%$146.43
06/08/201506/25/2015$0.6251.31%1.54%$161.89
03/06/201503/25/2015$0.6251.33%1.72%$145.16
12/03/201412/22/2014$0.4381.35%1.35%$129.16
09/08/201409/25/2014$0.4381.43%1.48%$118.13
06/06/201406/25/2014$0.4381.53%1.65%$106.13
03/06/201403/25/2014$0.4381.71%1.91%$91.52
12/05/201312/23/2013$0.3751.67%1.67%$89.78
09/06/201309/25/2013$0.3751.62%1.72%$87.29
06/06/201306/25/2013$0.3751.73%1.96%$76.44
03/06/201303/25/2013$0.3751.98%2.4%$62.52
12/05/201212/21/2012$0.2872.05%2.05%$56.10
09/06/201209/25/2012$0.2881.86%1.93%$59.72
06/06/201206/25/2012$0.2881.6%1.71%$67.27
03/07/201203/23/2012$0.2881.63%1.8%$63.84
12/07/201112/23/2011$0.2501.46%1.46%$68.51
09/07/201109/23/2011$0.2501.17%1.56%$64.14
06/08/201106/24/2011$0.2500.66%1.32%$75.52
03/08/201103/25/2011$0.2500.37%1.46%$68.33

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for ELV

Based on past 10-year performance, here are ELV growth metrics:

Share price CAGR of +11.04%
Dividend CAGR of +14.06%
Using ELV CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

ELV
Current Price$365.96
Start Shares27.33
Start Value$10,000
 
After 10 years:
Final Share Count33.41
Dividends Payment$6.07
Annual Dividends$812
Yield on cost8.12%
Share Price$938.86
Total Dividends$3,881
Final Value$31,370

Estimated Future Value + Dividends - ELV

NOTE: Above numbers are our estimate based on ELV's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Elevance Health Inc. (ELV) had its IPO on 2001-10-30, and is trader on NYSE stock exchange.

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

ELV website: https://www.elevancehealth.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial